Omada Health

Omada Health

OMDA
Omada HealthUS flagNASDAQ Global Market
22.29
USD
-1.02
- -
1.33BMarket Cap

Total Valuation

Omada Health carries a market capitalization of 1.33B, placing it among publicly traded companies globally. Its enterprise value stands at 1.11B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.33B
Enterprise Value1.11B

Share Statistics

Omada Health currently has 60.61M shares outstanding.

Shares Outstanding60.61M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Omada Health trades at a trailing price-to-earnings ratio of 298.69. The price-to-sales ratio is 4.15, and the price-to-book ratio stands at 5.26.

PE Ratio298.69
PS Ratio4.15
PB Ratio5.26
P/TBV Ratio5.59
P/FCF Ratio54.43
P/OCF Ratio54.29

Enterprise Valuation

On an enterprise value basis, Omada Health trades at an EV/EBITDA multiple of 204.12 and an EV/FCF ratio of 44.27.

EV / Sales3.58
EV / EBITDA204.12
EV / EBITN/A
EV / FCF44.27

Financial Position

Omada Health maintains a current ratio of 3.91, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities.

Current Ratio3.91
Quick Ratio3.69
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage13.65

Financial Efficiency

Omada Health posts a return on equity of 1.84 and a return on invested capital of -0.19.

Return on Equity (ROE)1.84
Return on Assets (ROA)1.36
Return on Invested Capital (ROIC)-0.19
Return on Capital Employed (ROCE)1.89
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover25.97

Stock Price Statistics

Omada Health's stock has declined approximately -5.39049% over the past 52 weeks. The 50-day moving average sits at 22.52, while the 200-day moving average is 16.96.

Beta (5Y)N/A
52-Week Price Change-5.39049%
50-Day Moving Average22.52
200-Day Moving Average16.96
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Omada Health generated 309.76M in revenue and converted that into 4.31M in net income, yielding earnings per share of 0.07. EBITDA reached 5.43M, while operating income came in at -464,000.00.

Revenue309.76M
Gross Profit211.21M
Operating Income-464,000.00
Pretax Income4.31M
Net Income4.31M
EBITDA5.43M
EBIT-464,000.00
Earnings Per Share (EPS)0.07

Balance Sheet

Total book value stands at 252.74M, with working capital of 219.43M providing operational flexibility.

Cash & Cash Equivalents221.71M
Total DebtN/A
Net Debt-221.71M
Equity (Book Value)252.74M
Book Value Per Share4.17
Working Capital219.43M

Cash Flow

Omada Health produced 23.69M in operating cash flow over the past twelve months. After subtracting -960,000.00 in capital expenditures, free cash flow totaled 22.73M - equivalent to 0.39 per share.

Operating Cash Flow23.69M
Capital Expenditures-960,000.00
Free Cash Flow22.73M
FCF Per Share0.39

Margins

Omada Health operates with a gross margin of 68.19, reflecting its pricing power and cost economics. The operating margin of -0.15 and net profit margin of 1.39 provide insight into operational efficiency.

Gross Margin68.19
Operating Margin-0.15
Pretax Margin1.39
Profit Margin1.39
EBITDA Margin1.75

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield1.40
FCF Yield1.84

Scores

Omada Health posts an Altman Z-Score of 10.37, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score10.37